Arcturus Therapeutics Holdings

$40.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (+2.05%) Today
+$0.17 (+0.42%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ARCT and other stocks, options, and ETFs commission-free!

About ARCT

Arcturus Therapeutics Holdings Inc. Common Stock, also called Arcturus Therapeutics Holdings, is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases.

CEO
Joseph E. Payne
Employees
118
Headquarters
San Diego, California
Founded
2013
Market Cap
1.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
616.47K
High Today
$40.41
Low Today
$38.53
Open Price
$39.75
Volume
515.35K
52 Week High
$129.71
52 Week Low
$17.00

ARCT Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

NGACW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure